- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT01287377
Smoking Cessation With the Nicotine Patch: A Pilot Study of Patch Messaging
The primary purpose of this study is to test the feasibility of sending pre-cessation nicotine patches and to examine the effects associated with the pre-cessation treatment phase. Specifically, this study aims to:
- See if subjects will use pre-cessation nicotine patches.
- See if subjects in the pre-cessation nicotine patches go on to get more nicotine patches.
- See if pre-cessation treatment with nicotine patches leads to a decrease in number of cigarettes smoked per day.
- See if sending 2-weeks' worth of patches is helpful to the quitting process.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
Quitlines have become central to state tobacco control efforts in the U.S. In addition to offering telephone counseling, many quitlines have begun providing quitting aids (e.g., nicotine patch) to eligible smokers. The nicotine patch has been shown repeatedly to double the rate of quitting success compared to a placebo control. Recently a number of studies have examined the use of patches prior to quitting. A meta-analysis indicates that such pre-cessation treatment with nicotine patches doubles the odds of quitting, compared to starting patch treatment on the quit day, as is traditionally done.
The proposed study would look at both pre-cessation treatment with nicotine patches as well as looking to see if sending clients nicotine patches is helpful in their quitting process. The rationale for pre-cessation treatment with patches is that using patches in this manner would make it easier to quit smoking because it may: reduce the reinforcing effects of cigarette smoking, thus helping to overcome conditioned behavior; reduce the need for inhaled nicotine as smokers naturally decrease their cigarette consumption to titrate the level of nicotine in their system; and/or increase compliance with patch use in the quitting phase.
The rationale for sending nicotine patches is that when callers must go and get the patches on their own it creates a barrier to their quitting so that sending nicotine patches directly to a callers' home would make it easier for them to stay on task and quit. This pilot will allow us to test the feasibility of sending pre-treatment nicotine patches and to examine the effects associated with the pre-cessation treatment phase.
This pilot project has the following specific aims, to examine whether:
- Subjects will use pre-cessation nicotine patches.
- Subjects in the pre-cessation nicotine patches go on to get more nicotine patches.
- Pre-cessation treatment with nicotine patches leads to a decrease in number of cigarettes smoked per day.
- Sending 2-weeks' worth of patches is helpful to the quitting process.
Results will add to the theoretical understanding of behavior change from which new, effective interventions can spring.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Fase 3
Contatti e Sedi
Luoghi di studio
-
-
California
-
San Diego, California, Stati Uniti, 92111
- University of California San Diego
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- >= 18 years old
- Daily smoker
- >=10 cigarettes per day
- Ready to quit within one month
- First time quitline caller
- Valid phone number
- Valid address (no P.O. boxes)
- California resident
- Agree to participate in study and evaluation
- English speaking
Exclusion Criteria:
- Uses other form of tobacco
- Plan to use quitting aids other than nicotine patch
- Has any of the following conditions:
- Severe allergy to adhesive tape
- Arrhythmia
- Angina
- Heart attack within last 6 months
- Stroke within last 6 months
- Uncontrolled high blood pressure
- Insulin-dependent diabetes
- Pregnancy
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Pre-Patch and Telephone Counseling
Nicotine patches (2 weeks' worth) are mailed directly to the subject. Clients will be encouraged to start using these patches PRIOR to their quit date. Counseling includes a comprehensive pre-quit session (to include motivation, planning, discussion of nicotine patch use, and setting of a quit date) and up to 4 proactive follow-up calls. |
Telephone counseling has several distinguishing features, namely proactive follow up counseling calls, a manualized protocol, and relapse-sensitive scheduling.
The follow-up call schedule includes a reminder call if the quit date is more than one week out, a call within 24 hours of the quit attempt, another call 4-7 days after the quit date, and another call 10-14 days after the quit date.
Subjects are randomized into one of these pharmacotherapy interventions: direct mailing of active patches with a message to start using it on their quit date, direct mailing of active patches with a message to start using it right away, or usual care patches in which no patches are sent directly (although clients may still get them through their usual channels). For those in the usual care condition, patches will not be mailed directly to them; however, we will facilitate their use by providing a certificate that can be used by the State Medicaid program and some other insurance companies to obtain free patches. For those in the active condition, we will mail 2 weeks of patches directly to their home. All subjects will receive a 2 week starter kit with fourteen 21mg patches.
Altri nomi:
|
|
Comparatore attivo: Post-Patch and Telephone Counseling
Nicotine patches (2 weeks' worth) are mailed directly to the subject. Clients are encouraged to start using their patches ON their quit date. Counseling includes a comprehensive pre-quit session (to include motivation, planning, discussion of nicotine patch use, and setting of a quit date) and up to 4 proactive follow-up calls. |
Telephone counseling has several distinguishing features, namely proactive follow up counseling calls, a manualized protocol, and relapse-sensitive scheduling.
The follow-up call schedule includes a reminder call if the quit date is more than one week out, a call within 24 hours of the quit attempt, another call 4-7 days after the quit date, and another call 10-14 days after the quit date.
Subjects are randomized into one of these pharmacotherapy interventions: direct mailing of active patches with a message to start using it on their quit date, direct mailing of active patches with a message to start using it right away, or usual care patches in which no patches are sent directly (although clients may still get them through their usual channels). For those in the usual care condition, patches will not be mailed directly to them; however, we will facilitate their use by providing a certificate that can be used by the State Medicaid program and some other insurance companies to obtain free patches. For those in the active condition, we will mail 2 weeks of patches directly to their home. All subjects will receive a 2 week starter kit with fourteen 21mg patches.
Altri nomi:
|
|
Comparatore attivo: Telephone Counseling and no patches sent
Counseling includes a comprehensive pre-quit session (to include motivation, planning, discussion of nicotine patch use, and setting of a quit date) and up to 4 proactive follow-up calls.
|
Telephone counseling has several distinguishing features, namely proactive follow up counseling calls, a manualized protocol, and relapse-sensitive scheduling.
The follow-up call schedule includes a reminder call if the quit date is more than one week out, a call within 24 hours of the quit attempt, another call 4-7 days after the quit date, and another call 10-14 days after the quit date.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Number of Participants Who Have Not Used Tobacco in the Past 30 Days
Lasso di tempo: 2-months post enrollment
|
At a given point in time (in this case, 2 months after program registration), quitline participants are asked whether they have used cigarettes or other forms of tobacco in the past 30 days.
Those who reply that they have not used tobacco in the past 30 days are considered to have quit.
|
2-months post enrollment
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Number of Participants With Serious Quit Attempts
Lasso di tempo: 2-months post enrollment
|
A serious quit attempt is considered is a quit attempt that last more than 24 hours
|
2-months post enrollment
|
Collaboratori e investigatori
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 100683
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Smettere di fumare
-
Poitiers University HospitalNon ancora reclutamentoTerapia sostitutiva della nicotina | Professionisti sanitari | Desiderio di Tabacco | Tabacco CessationFrancia
Prove cliniche su Telephone Counseling
-
Duke UniversityCompletatoCessazione dell'uso del tabaccoStati Uniti
-
Saglik Bilimleri Universitesi Gulhane Tip FakultesiCompletatoFemmina di cancro al seno
-
Pakistan Institute of Medical SciencesReclutamentoContraccezionePakistan
-
TC Erciyes UniversityThe Scientific and Technological Research Council of TurkeyCompletatoTinnito cronicoTurchia (Türkiye)
-
Centers for Disease Control and PreventionState University of New York - Downstate Medical CenterCompletatoClamidia Trachomatis | Neisseria gonorrhoeaeStati Uniti
-
Tonia CarrRitiratoAderenza ai farmaci | Evento avverso da farmaci | Non aderenza ai farmaciStati Uniti
-
Swiss Tropical & Public Health InstituteUniversity of Basel; Ministry of Health, Lesotho; SolidarMedCompletatoHIV/AIDS | Aderenza, FarmacoLesoto
-
UKK InstituteCity of NokiaIscrizione su invitoQualità della vita | Dolore muscoloscheletrico | Attività fisica | Funzionamento fisicoFinlandia
-
The University of Hong KongCompletato
-
Andrew Weeks MD MRCOGUniversity of Liverpool; University College Hospital, Ibadan, NigeriaCompletatoDisordine depressivo | Disturbi d'ansia | Disagio psicologico | Stress psicologico | Infertilità/sterilitàNigeria